| Autor: |
Georgopoulou, A. N., Vassilakopoulos, T. P., Panayiotidis, P., Siakantaris, M., Keramaris, K., Georgopoulos, N. A., Kalantaridou, S., Arapaki, M., Chatzidimitriou, C., Kopsaftopoulou, A., Mamali, I., Angelopoulou, M. K. |
| Předmět: |
|
| Zdroj: |
Hematological Oncology; Jun2023 Supplement S2, Vol. 41, p679-680, 2p |
| Abstrakt: |
Measurements were performed at pre-specified time points: before treatment (t0), during CT(t1), at the end of CT(t2) and every six months (t6, t12) thereafter. In men, spermatogenesis (Sertoli cells), reflected by the increased levels of FSH, was impaired for 1 year after the end of CT, while testosterone transiently increased, possibly as a result of treatment toxicity to Leydig cells. B Background: b ABVD or escBEACOPP chemotherapy (CT) ± radiation is the treatment approach for Hodgkin lymphoma (HL) patients. [Extracted from the article] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
Plný text